Order Article Reprints

Oswald LB, Gudenkauf LM, Li X, De Avila G, Peres LC, Kirtane K, Gonzalez BD, Hoogland AI, Nguyen O, Rodriguez Y, et al. Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel. Cancers. 2023; 15(19):4711. https://doi.org/10.3390/cancers15194711

Oswald, Laura B., Lisa M. Gudenkauf, Xiaoyin Li, Gabriel De Avila, Lauren C. Peres, Kedar Kirtane, Brian D. Gonzalez, Aasha I. Hoogland, Oanh Nguyen, Yvelise Rodriguez, and et al. 2023. "Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel" Cancers 15, no. 19: 4711. https://doi.org/10.3390/cancers15194711

Oswald, L. B., Gudenkauf, L. M., Li, X., De Avila, G., Peres, L. C., Kirtane, K., Gonzalez, B. D., Hoogland, A. I., Nguyen, O., Rodriguez, Y., Baz, R. C., Shain, K. H., Alsina, M., Locke, F. L., Freeman, C., Castaneda Puglianini, O., Nishihori, T., Liu, H., Blue, B., ... Hansen, D. K. (2023). Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel. Cancers, 15(19), 4711. https://doi.org/10.3390/cancers15194711